Gadavist 7.5 mmol/7.5 ML vial 7.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM1ZY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,955
Award facts
- Contract value 100% obligated
- $1,955.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,955.20 to AmerisourceBergen Drug Corp for the supply of Gadavist 7.5 mmol/7.5 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of January 9, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and is a subsidiary of Cencora, Inc. The company fulfills this delivery order under a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which enables the company to supply a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally.
Gadavist is a contrast agent used in medical imaging procedures, representing the type of specialized pharmaceutical commodity that AmerisourceBergen delivers through its federal contract portfolio. The company's extensive experience supplying medications across multiple therapeutic domains—including specialty drugs, generic medications, vaccines, and medical devices—positions it as a critical vendor supporting Defense Health Agency operations and other military healthcare systems. As the primary contractor on this delivery order with no identified subcontractors, AmerisourceBergen maintains responsibility for fulfilling federal medical supply requirements across therapeutic applications essential to military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FM1ZY?
SPE2DR26FM1ZY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FM1ZY worth?
The government has obligated $1,955 on SPE2DR26FM1ZY.
Is contract SPE2DR26FM1ZY an order under another contract?
Yes. SPE2DR26FM1ZY is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1ZY competed?
The extent of competition for SPE2DR26FM1ZY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award